Ticker
ARVNCompany Name
ARVINAS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Shareholders Equity | Market Capitalization | Price to Book |
---|---|---|---|
6/30/2025 | $ 609.3M | $ 472.08M | 0.77 |
3/31/2025 | $ 660.1M | $ 527.73M | 0.8 |
12/31/2024 | $ 561.7M | $ 1.22B | 2.16 |
9/30/2024 | $ 586M | $ 1.9B | 3.24 |
6/30/2024 | $ 600.2M | $ 1.86B | 3.1 |
3/31/2024 | $ 609.7M | $ 2.35B | 3.85 |
12/31/2023 | $ 660M | $ 3.27B | 4.95 |
9/30/2023 | $ 457.2M | $ 978.9M | 2.14 |
6/30/2023 | $ 463.6M | $ 1.3B | 2.8 |
3/31/2023 | $ 511M | $ 1.35B | 2.64 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Market Cap / Equity
(=) P/B
P/B for ARVINAS INC is calculated as follows: Market Cap [ $ 902.21M ] / Equity [ $ 205.12M ]
(=) P/B [ 4.4 ]
Minimum
Jun 30, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.36K |
---|---|
min | 0 |
max | 8.04 |
average | 2.29 |
median | 1.63 |
std | 1.81 |